IL1R2 is a Novel Prognostic Biomarker for Lung Adenocarcinoma.

Aims: The aim of this study is to figure out the role of IL1R2 in LUAD (lung adenocarcinoma).

Background: IL1R2, a special member of IL-1 receptor family, binds to IL-1 and plays an important role in inhibiting IL-1 pathway, which seems to be involved in tumorigenesis. Emerging studies demonstrated higher IL1R2 expression levels in several malignancies.